Panitumumab

The initial genetics came back on my tumor and it has wild-type KRAS and NRAS genes. As a result, my second round of chemo, which I had today, switched from FOLFIRINOX to FOLFIRI + Panitumumab. Panitumumab is a targeted therapy using monoclonal antibodies.